Published in Women's Health Weekly, January 15th, 2000
The goals of the new study are to determine whether fenretinide can stop the development of ovarian cancer, to identify...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.